Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;94:340-345

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamakawa, H.
Right arrow Articles by Yokoyama, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamakawa, H.
Right arrow Articles by Yokoyama, M.

(Circulation. 1996;94:340-345.)
© 1996 American Heart Association, Inc.


Articles

Negative Chronotropic Effect of ß-Blockade Therapy Reduces Myocardial Oxygen Expenditure for Nonmechanical Work

Hideyuki Yamakawa, MD; Motoshi Takeuchi, MD; Hideyuki Takaoka, MD; Katsuya Hata, MD; Masuki Mori, MD; Mitsuhiro Yokoyama, MD

the First Department of Internal Medicine, Kobe University School of Medicine, Kobe, Japan.

Correspondence to Motoshi Takeuchi, MD, First Department of Internal Medicine, Kobe University School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650, Japan.

Background The negative chronotropic effect of ß-blocking agents is likely to provide hemodynamic and energetic advantages. However, the negative chronotropic effect on cardiac energetics observed on the initiation of ß-blockade therapy has not been fully elucidated.

Methods and Results In 18 patients with heart failure, left ventricular pressure and volume, external work (EW), myocardial oxygen consumption per beat (total O2), mechanical efficiency (EW/total O2), and O2 for nonmechanical work (total O2-2·EW) were measured with the use of conductance catheter and Webster catheter at the following three states: under control conditions and after ß-blockade (0.15±0.07 mg/kg propranolol IV) with and without atrial pacing to keep the heart rate at control levels. Heart rate decreased after atrial pacing was stopped. EW decreased during ß-blockade with pacing and returned to the control level after pacing was stopped. Total O2 did not change during ß-blockade with or without pacing, whereas O2 for nonmechanical work increased with pacing and returned to the control level after pacing was stopped. As a result, mechanical efficiency decreased during ß-blockade with pacing and returned to the control level after pacing was stopped.

Conclusions The negative chronotropic effect of a ß-blocking agent may offset the mechanoenergetical deterioration resulting from its negative inotropic effect through a reduction in oxygen expenditure for nonmechanical work. These findings suggest that the negative chronotropic effect is an important aspect of ß-blockade therapy.


Key Words: heart failure • ß-adrenergic receptor blockade • heart rate • energetics




This article has been cited by other articles:


Home page
Eur J Heart FailHome page
D. Logeart, J.-P. Gueffet, F. Rouzet, F. Pousset, C. Chavelas, A. C. Solal, and G. Jondeau
Heart rate per se impacts cardiac function in patients with systolic heart failure and pacing: a pilot study
Eur J Heart Fail, January 1, 2009; 11(1): 53 - 57.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A.H. Stewart, O. C. Raffel, A. J. Kerr, R. Gabriel, I. Zeng, A. A. Young, and B. R. Cowan
Pilot Study to Assess the Influence of {beta}-Blockade on Mitral Regurgitant Volume and Left Ventricular Work in Degenerative Mitral Valve Disease
Circulation, September 2, 2008; 118(10): 1041 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. Ferrari, C. Ceconi, and G. Guardigli
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction
Eur. Heart J. Suppl., August 1, 2008; 10(suppl_F): F7 - F10.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Ciobotaru, M. Heimburger, L. Louedec, C. Heymes, R. Ventura-Clapier, P. Bedossa, B. Escoubet, J.-B. Michel, J.-J. Mercadier, and D. Logeart
Effect of Long-Term Heart Rate Reduction by If Current Inhibition on Pressure Overload-Induced Heart Failure in Rats
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 43 - 49.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Fox, J. S. Borer, A. J. Camm, N. Danchin, R. Ferrari, J. L. Lopez Sendon, P. G. Steg, J.-C. Tardif, L. Tavazzi, M. Tendera, et al.
Resting Heart Rate in Cardiovascular Disease
J. Am. Coll. Cardiol., August 28, 2007; 50(9): 823 - 830.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Yamada, K. A. Mowrey, Z. B. Popovic, W. J. Kowalewski, D. O. Martin, J. D. Thomas, and D. W. Wallick
Coupled pacing improves cardiac efficiency during acute atrial fibrillation with or without cardiac dysfunction
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2016 - H2022.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Mansfield, D. M. Kaye, H. Brunner La Rocca, P. Solin, M. D. Esler, and M. T. Naughton
Raised Sympathetic Nerve Activity in Heart Failure and Central Sleep Apnea Is Due to Heart Failure Severity
Circulation, March 18, 2003; 107(10): 1396 - 1400.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. M. Kaye, L. Johnston, G. Vaddadi, H. Brunner-LaRocca, G. L. Jennings, and M. D. Esler
Mechanisms of Carvedilol Action in Human Congestive Heart Failure
Hypertension, May 1, 2001; 37(5): 1216 - 1221.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T Laperche, D Logeart, A Cohen-Solal, and R Gourgon
Potential interests of heart rate lowering drugs
Heart, April 1, 1999; 81(4): 336 - 341.
[Full Text]


Home page
HeartHome page
J E Sanderson, S K W Chan, C M Yu, L Y C Yeung, W M Chan, K Raymond, K W Chan, and K S Woo
beta Blockers in heart failure: a comparison of a vasodilating beta  blocker with metoprolol
Heart, January 1, 1998; 79(1): 86 - 92.
[Abstract] [Full Text] [PDF]